⌘K

Login Start Free

Home/Filings/4/0001144204-16-106799

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001144204-16-106799

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:51 PM ET

Size

5.5 KB

Accession

0001144204-16-106799

Insider Transaction Report

Form 4

Period: 2016-06-01

IMMUNE PHARMACEUTICALS INCIMNP

Luchi Monica E.

EVP & CMO

Transactions

Award
Stock Option
2016-06-01+180,000→ 580,000 total
Exercise: $0.40Exp: 2026-06-01→ Common Stock (180,000 underlying)

Footnotes (1)

[F1]The stock options shall vest over a period of three years, with 1/3 of the options vesting on the first anniversary of the date of grant and the remainder vesting quarterly over the following two-year period.

Documents

1 file

4
v441648_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:51 PM ET
Size: 5.5 KB

View on SEC.gov